Obesity / weight management
Medical weight management treats obesity as a metabolic condition, not a matter of willpower. A major 2025 international guideline (the Lancet Commission on Clinical Obesity) now distinguishes "preclinical obesity" (excess body fat without complications yet) from "clinical obesity" (excess body fat that has already caused health complications), changing how and when treatment is prioritized — and in India specifically, BMI thresholds are lower than global averages, reflecting higher metabolic risk at a given weight.
Your weight management assessment pathway
Body Composition Assessment
BMI plus at least one other measure — such as waist circumference — rather than BMI alone.
Determining Preclinical vs. Clinical Obesity
Checking whether excess body fat has already led to health complications.
Screening for Related Metabolic Conditions
Blood glucose, blood pressure, and cholesterol, since weight rarely sits in isolation.
Setting Your Personal Goals
Individualized, realistic goals rather than a generic target weight.
Building Your Plan
Nutrition and activity as the foundation, with medical therapy considered where appropriate.
Follow-Up and Adjustment
Weight management is reviewed and adjusted over time, not treated as a single intervention.
Symptoms
- Elevated body mass index (BMI) or abdominal circumference
- Often no symptoms directly, but connected to fatigue, joint strain, and metabolic changes
Causes & risk factors
- A combination of genetic, metabolic, behavioral, and environmental factors
- Insulin resistance
- Certain medications
- Sleep and stress factors that affect weight regulation
Nationally, generalized obesity affects an estimated 28.6% of Indian adults (ICMR-INDIAB national study (Anjana et al., Lancet Diabetes & Endocrinology, 2023)).
Redefining obesity: preclinical vs. clinical
A major 2025 international commission, endorsed by more than 75 medical organizations, reframed how obesity itself is defined and treated.
| Category | What it means | Approach |
|---|---|---|
| Preclinical obesity | Excess body fat that hasn't yet caused organ dysfunction or health complications | Monitored as a future risk factor, addressed with prevention-focused measures |
| Clinical obesity | Excess body fat that has already led to complications (e.g., high blood pressure, sleep apnea, joint pain, obesity-linked heart strain) | Treated as a standalone illness requiring direct, individualized intervention |
Body fat
Excess adiposity is the starting point for assessment, not weight or BMI alone
Metabolic risk
Excess body fat carries future metabolic risk even before it causes visible complications
Complications
Once excess fat causes organ dysfunction, obesity is treated as a standalone illness
Why BMI alone isn't enough
BMI is a useful starting point, but it can't tell the difference between fat and muscle, or show where fat is distributed — both of which matter for your actual metabolic risk.
- Current guidance recommends BMI plus at least one additional measure — waist circumference, waist-to-hip ratio, or waist-to-height ratio — or, where available, a direct measurement such as a DEXA scan
- Two people with the same BMI can have meaningfully different metabolic risk depending on how and where their body carries fat
BMI thresholds are different in India
This is a genuinely important, often-overlooked detail — using a general global BMI cutoff can understate risk for Indian patients.
Lower thresholds, not stricter ones
- ICMR guidelines set India-specific BMI thresholds lower than the global general-population standard: overweight begins at BMI 23 or above, and obesity at BMI 25 or above (versus 25 and 30 globally)
- This reflects that Indians tend to accumulate more visceral (internal, abdominal) fat, and develop metabolic risk, at a lower body weight than Western populations studied for the original global thresholds
- This is the same pattern behind the lower South Asian cutoffs already used for waist circumference and cardiovascular risk assessment elsewhere on this site — a consistent, evidence-based adjustment, not an inconsistency between guidelines
How weight is treated: a staged approach
Treatment intensifies in stages — most patients don't need every option, and the right stage depends on your specific findings and risk.
| Approach | What it involves | Who it's typically for |
|---|---|---|
| Lifestyle measures | Nutrition changes and regular physical activity | The foundation for everyone, regardless of what else is added |
| Medical therapy | Medication, including GLP-1-based options where appropriate | Patients whose risk profile and goals support adding medication — see our GLP-1 therapy page |
| Metabolic/bariatric surgery | Surgical options for more significant, sustained weight loss | Generally BMI 35+ regardless of other conditions, or lower (around 27.5+ in Asian populations, per adjusted criteria) alongside obesity-related health conditions |
Setting realistic goals
Success in weight management isn't defined by reaching a specific target weight — it's defined by meaningful health improvement, which happens well before that.
A 7–10% reduction in body weight is associated with meaningful improvement in blood glucose, blood pressure, cholesterol, and liver fat for many patients. Larger reductions can add further benefit, but this range is a genuinely useful, achievable first goal rather than an arbitrary one.
Follow-up and long-term management
Weight management works best as ongoing care rather than a single intervention — your plan is reviewed and adjusted over time as your weight, metabolic markers, and life circumstances change, since regain after any single intervention (lifestyle, medication, or surgery) is a well-recognized pattern that's addressed through continued follow-up, not treated as a failure.
How it’s diagnosed
Assessment includes BMI plus at least one additional measure (such as waist circumference), and screening for related metabolic conditions (blood glucose, blood pressure, cholesterol) — evaluating weight as part of overall metabolic health, and distinguishing preclinical from clinical obesity based on whether complications are already present.
How it’s treated
Management is staged and individualized: nutrition and physical activity form the foundation, with medical therapy (including GLP-1 based options where appropriate) considered for some patients based on their overall risk profile, and metabolic/bariatric surgery reserved for specific, more significant situations. See the GLP-1 therapy treatment page for more on that option specifically.
When to seek care
- You'd like a structured, medical evaluation of weight and metabolic risk rather than a generic diet plan
- Weight changes alongside other symptoms (fatigue, thirst, changes in periods)
- Signs of sleep apnea — loud snoring, gasping during sleep, or significant daytime sleepiness
- Joint pain that's limiting your mobility
FAQ
Is medication the first step for weight management?
No. Nutrition and activity remain the foundation of care; medication is one option considered alongside those, individualized to each patient's risk profile and goals.
What's the difference between overweight/obesity by BMI and "clinical obesity"?
BMI-defined overweight or obesity is a body-size category. "Clinical obesity" is a newer, more specific term for excess body fat that has already caused health complications — treated as a standalone illness rather than just a risk factor.
Why did the definition of obesity change?
A 2025 international commission, endorsed by more than 75 medical organizations, redefined obesity to better target monitoring and treatment by actual risk and harm, rather than treating everyone above a BMI cutoff the same way.
Are BMI thresholds different for Indians?
Yes — ICMR guidelines set India-specific thresholds lower than the global standard (overweight from BMI 23, obesity from BMI 25, versus 25 and 30 globally), reflecting higher metabolic risk at a given weight in Indian populations.
What other measurements are used besides BMI?
Waist circumference, waist-to-hip ratio, waist-to-height ratio, or, where available, a direct measurement such as a DEXA scan — since BMI alone can't distinguish fat from muscle or show fat distribution.
How much weight loss actually helps?
A 7–10% reduction in body weight is associated with meaningful improvement in blood glucose, blood pressure, cholesterol, and liver fat for many patients — a genuinely useful first goal, not just a token amount.
When is medication considered for weight management?
When lifestyle measures alone aren't sufficient for your individual risk profile and goals — medication is added alongside, not instead of, nutrition and activity changes.
When is bariatric or metabolic surgery considered?
Generally for a BMI of 35 or above regardless of other conditions, or lower (around 27.5 and above in Asian populations, per adjusted criteria) alongside obesity-related health conditions such as diabetes or sleep apnea.
Is bariatric surgery safe?
It's an established, well-studied option for appropriately selected patients, with its own specific criteria and risks discussed individually — it isn't a first-line option and is considered alongside, not instead of, medical evaluation.
Is weight regain common after treatment?
It's a well-recognized pattern after any single intervention — lifestyle, medication, or surgery — which is why weight management is treated as ongoing care with regular follow-up, not a one-time fix.
Is obesity a disease, or a lifestyle issue?
Current medical understanding treats obesity as a metabolic condition shaped by genetic, metabolic, behavioral, and environmental factors together — not simply a matter of willpower, which is why it's assessed and treated medically rather than left to diet advice alone.
How is a thyroid cause of weight gain ruled out?
With a simple TSH blood test as part of your overall metabolic assessment — see our thyroid disorders page for more detail on this connection.
Can PCOS cause weight gain?
Yes — polycystic ovary syndrome is commonly linked to insulin resistance and weight gain, and is considered as part of your evaluation, particularly alongside changes in menstrual cycles.
How often is weight and metabolic risk reassessed?
This depends on your individual plan and whether you're actively adjusting treatment — your care team will advise a follow-up schedule suited to your situation rather than a fixed interval for everyone.
Medical disclaimer: Content on this page is for general education and is not a substitute for individualized medical advice, diagnosis, or treatment. Outcomes vary between patients. Boston Diabetes Center is outpatient / day-care specialty centre with an on-site diagnostic lab and pharmacy — no inpatient beds; imaging and inpatient care are coordinated through partner facilities.